#COVIDbrain

2026-02-13

News Release 11-Feb-2026
Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID

eurekalert.org/news-releases/1

The Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary symptoms of #LongCOVID (REVERSE-LC)

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC

News Release 11-Feb-2026
Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID
Grant and Award Announcement
Vanderbilt University Medical Center

FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail
Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID 
image: 

Members of the Vanderbilt Health team are evaluating the efficacy of the immunomodulatory drug baricitinib for treating the persistent neurological and cardiopulmonary symptoms of long COVID.

view more 
Credit: (photo by Donn Jones)

Since the virus that causes COVID-19 emerged in late 2019, there have been over 780 million cases worldwide and over 7 million deaths. Despite the development of vaccines and effective therapeutics, millions of patients experience an often-devastating, post-acute infection syndrome known as long COVID (LC).

In the United States, it is estimated that up to 20 million adults with LC experience persistent neurocognitive impairments (NCI) and cardiopulmonary symptoms such as dyspnea (shortness of breath) and exercise intolerance for months to years after having COVID-19. The public health burden of LC is estimated to be the largest seen from an emerging disease in the past century, yet there remain no effective interventions.
2026-02-13

"WHO/Europe, with support from the EU, has developed 8 long COVID myth-busters that use evidence-based information and real patient stories to clear up these myths and promote scientifically accurate understanding."

who.int/europe/news-room/event

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #auscovid19 #CovidIsNotOver

@novid #novid

Europe

Home/Newsroom/Events/Myth-busters: debunking long COVID myths and misconceptions
©
Myth-busters: debunking long COVID myths and misconceptions
30 January – 31 March 2026
Русский
Deutsch
Misconceptions about post COVID-19 condition, more commonly known as long COVID, continue to hinder diagnosis, prevention, care and rehabilitation.

To debunk these myths and misconceptions, WHO/Europe, with support from the European Union, has developed 8 long COVID myth-busters that use evidence-based information and real patient stories to clear up these myths and promote scientifically accurate understanding.
2026-02-12

"we observed sustained negative impacts of PCC on health outcomes 2.5 years after initial COVID-19 in non-hospitalised individuals, despite minor improvements over time."

link.springer.com/article/10.1

Screenshot from latest Science for ME weekly update

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #auscovid19 #CovidIsNotOver

Long-term health outcomes and risk factors for low self-rated health in non-hospitalised adults with post-COVID-19 condition: a 2.5-year cohort study — Törnberg et al.
"we observed sustained negative impacts of PCC on health outcomes 2.5 years after initial COVID-19 in non-hospitalised individuals, despite minor improvements over time."
2026-02-12

SARS-CoV-2 reinfections and subsequent risk of hospital-diagnosed post-acute sequelae in Denmark (2020–2022): a nationwide cohort study

sciencedirect.com/science/arti

Screenshot from latest Science for ME weekly update

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #auscovid19 #CovidIsNotOver

SARS-CoV-2 reinfections and subsequent risk of hospital-diagnosed post-acute sequelae in Denmark (2020–2022): a nationwide cohort study — Khurana et al.
"Of 4,418,544 individuals, 6942 (0.16%) were diagnosed with long COVID." "diagnoses were made in hospital settings and thus predominantly capture severe presentations. As a result, only a fraction of individuals experiencing postacute sequelae are likely represented, underestimating the true risk"
2026-02-11

From Australia:

Non-invasive electrodiagnostic testing for small fibre neuropathy in long COVID-19

neurologyopen.bmj.com/content/

Screenshot from latest Science for ME weekly update

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #auscovid19 #CovidIsNotOver
#SFN

Non-invasive electrodiagnostic testing for small fibre neuropathy in long COVID-19 — Anthony Khoo et al.
"Notably, we demonstrated different combinations of abnormality among the four small fibre neuropathy tests illustrating the benefit of multimodal SFN testing protocols which interrogate different small nerve fibres."
2026-02-11
NET Biomarkers in COVID-19 and Post-COVID Syndrome: a Comprehensive Analysis — Monsalve et al.
"Our findings revealed a significant increase in NET biomarkers during acute COVID-19 that persisted in PCS. This pattern was consistent with the in vitro study, where sera from PCS patients induced NET release."
2026-02-07

Australian Winter Olympic athletes wearing an N95 mask as they boarded the bus to head to the Opening Ceremony
👏👏👍👍

Hashtags:

@longcovid
#LongCovid #PwLC #PostCovidSyndrome #LC #PASC #postcovid
#CovidBrain
#COVIDー19 #COVID19 #COVID #COVID_19 #SARSCoV2 @novid #novid #CovidIsNotOver #auscovid19
#Masking #Maskup

1/

Photo of athletes wearing blue and yellow wearing masks
2026-02-04

New from international research group

Immunoglobulin G Complexes from Post-infectious ME/CFS, including post-COVID ME/CFS Disrupt Cellular Energetics and Alter Inflammatory Marker Secretion

sciencedirect.com/science/arti

#MEcfs #CFS #PwME #MyalgicEncephalomyelitis #ChronicFatigueSyndrome
@mecfs
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC

1/

Abstract
Background
Autoimmunity is a key clinical feature in both post-infectious Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Post-Acute Sequelae of COVID (PASC). Passive transfer of immunoglobulins from patients' sera into mice induces some clinical features of PASC. However, the physiological effects of immunoglobulins on cellular alterations remain elusive. In this study, we tested the potential effects of immunoglobulins from ME/CFS patients on endothelial cell dysfunction.
Methods
We have isolated immunoglobulins from 106 individuals, including ME/CFS (n=39), PCS-CFS (n=15), MS (n=20) patients, and healthy controls (n=41). Protein composition of the isolated immune complexes was studied using mass spectrometry. The effect of isolated immune complexes on mitochondria was evaluated using confocal microscopy and a Seahorse XFe96 Extracellular Flux Analyzer, and the impact on inflammatory cytokine secretion was studied using a multiplex bead-based assay.
Results
Here, we demonstrate that IgG isolated from post-infectious ME/CFS patients selectively induces mitochondrial fragmentation in human endothelial cells and alters cellular energetics. This effect is lost upon cleavage of IgG into its Fab and Fc fragments.
2026-02-04

The Stigma of self-report in health research: Time to reconsider what counts as “Objective” by Nisreen A. Alwan nisreen@mastodon.online

journals.plos.org/globalpublic

Screenshot from latest Science for ME weekly update

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC

The Stigma of self-report in health research: Time to reconsider what counts as “Objective” — Nisreen A. Alwan
"The assumption is that people misremember, exaggerate, or misinterpret their symptoms. But what if the problem lies not in the type of data, but in our unwillingness to trust this mode of reporting without adequate justification for such mistrust?"
2026-02-03

"the relationship between reporting persisting symptoms & increased healthcare consumption could not be explained by cognitive-behavioural factors, depressive symptoms or neuropsychological functioning."

link.springer.com/article/10.1

Screenshot from latest Science for ME weekly update

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2

Healthcare Consumption and Work Absenteeism of Individuals With and Without Persistent Complaints After COVID-19: The Role of Cognitive-Behavioural Factors, Neuropsychological Functioning and Depressive Symptoms — Verveen et al.
"the relationship between reporting persisting symptoms and increased healthcare consumption could not be explained by cognitive-behavioural factors, depressive symptoms or neuropsychological functioning."
2026-02-02

Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric Long COVID Development up to 12 Months
#PostCOVID19 Symptom Onset

biorxiv.org/content/10.64898/2

Screenshot from latest Science for ME weekly update

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #auscovid19 #CovidIsNotOver

Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric Long COVID Development up to 12 Months Post-COVID-19 Symptom Onset — Philip Samaan et al.
"our study highlights that neuropsychiatric long COVID symptoms may not be attributable to alterations in SARS-CoV-2-specific cellular or humoral immunity. However, diminished EBV-specific humoral immunity emerged as a potential risk factor for neuropsychiatric long COVID development"
2026-02-02

Imbalance of Excitatory and Inhibitory Neurotransmitter Systems in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

preprints.org/manuscript/20260

Screenshot from latest Science for ME weekly update

#MEcfs #CFS #PwME #MyalgicEncephalomyelitis #ChronicFatigueSyndrome @mecfs @longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC

Imbalance of Excitatory and Inhibitory Neurotransmitter Systems in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome — Klaus J. Wirth and Carmen Scheibenbogen
Hypothesis paper. "This paper reviews current knowledge on neurotransmitter systems implicated in ME/CFS and Long COVID, focusing on potential mechanisms of dysregulation and their roles in disease pathology and symptom generation, as well as implications for treatment."
2026-01-31

"Those Who Were Already Here: Learning to Live Inside a History I Did Not Choose"

centerleftstack.substack.com/p

Someone with long Covid eloquently thanks those with ME/CFS who have supported with advice, etc. the Long Covid new arrivals with similar symptoms & impairments

#MEcfs @longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#CFS #PwME #MyalgicEncephalomyelitis #ChronicFatigueSyndrome @mecfs

Those Who Were Already Here
Learning to Live Inside a History I Did Not Choose
Fred Rossi
Dec 24, 2025
Arrival Without a Map

When I first began trying to understand what was happening to my body, everything felt new. Not just new to me, but new in the way that feels destabilizing. As if the ground itself had shifted and no map existed.

Long COVID arrived wrapped in uncertainty. Doctors hesitated. Research lagged. Language failed. Each symptom seemed to require explanation from scratch. I thought I was living at the edge of something unprecedented.

That belief did not last.

Gradually, almost accidentally, I began encountering people who spoke about my present as if it were familiar. They used words I was just learning. Post-exertional malaise (PEM). Pacing. Crashes. Baseline. They described patterns that mirrored my days with unsettling precision. They were not speculating. They were remembering.

This was my introduction to the ME/CFS community. A community that had been here long before I arrived.

Recognition, Not Surprise

The people who live with ME/CFS did not greet Long COVID with surprise. They greeted it with recognition.

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst